Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Shift work is associated with a higher risk of the development of cardiometabolic syndrome (CMtS) than in people working only during the day. One of the factors predisposing to the development of the CMtS in shift workers is an inappropriate composition of their diet. It was observed that the shift workers diet is characterized by a higher intake of saturated fatty acids (SFA) and a lower consumption of unsaturated fatty acids. One potential way to reduce the risk of CMtS in this study group seems to be a modification of their everyday diet by excluding the products of animal origin (e.g. butter) with simultaneously including vegetable oils (i.e. canola oil). The aim of the study is to evaluate the effect of replacement in the everyday diet of saturated fats (butter) with unsaturated fats (canola oil-based spread and canola oil added to main meals) in centrally obese shift workers on changes in body weight and body composition parameters as well as on changes in CMtS markers.
The study was designed as a randomized clinical trial to investigate the effects of the dietary intervention with moderate in fat content (~35% energy as fat) for 12 weeks on the improvement of cardiometabolic risk factors in centrally obese shift workers. Forty centrally obese shift workers (waist circumference ≥94 cm) were randomized (1:1) to the experimental group (n = 20) or the control group (n = 20). Eligibility criteria included: aged between 30-60 years, working rotating shifts for at least 5 years and working night shifts minimum five times a month. Excluded criteria was described in the point "Eligibility". Written informed consent was obtained from all of the participants, and the local ethic committee approved the study. The dietary intervention was mainly based on the simple rearrangement of shift workers' diets by replacing food items including SFA (e.g. butter) with those being sources of unsaturated fatty acids (UFA), mainly canola oil (given to the diet as spread or this oil was added separately to main meals)
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention group | Experimental | Isocaloric diet, based on individual energy requirements calculated from indirect calorimetry and physical activity adjustment Participants will be asked to eat daily ~50g canola oil |
|
| Control group | Active Comparator | Standard dietary advice that is used as current best practice in the treatment of lipid disturbances of European Society of Cardiology and European Atherosclerosis Society (ESC/EAS) Guidelines for the management of dyslipidemias) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intervention group | Behavioral | Isocaloric diet including ~50g canola oil |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Waist circumference (WC) | Changes in WC within groups and between groups | Baseline, 4, 8 and 12 week |
| HDL-cholesterol (HDL-C) | Changes in HDL-C within groups and between groups | Baseline, 12 week |
| LDL-cholesterol (LDL-C) | Changes in LDL-C within groups and between groups | Baseline, 12 week |
| Triglycerides (TG) | Changes in TG within groups and between groups | Baseline, 12 week |
| Glucose (GLU) | Changes in GLU within groups and between groups | Baseline, 12 week |
| Blood pressure (BP) | Changes in BP within groups and between groups | Baseline, 12 week |
| Body weight (BW) | Changes in BW within groups and between groups | Baseline, 4, 8 and 12 week |
| Fat mass (FM) | Changes in FM within groups and between groups | Baseline, 4, 8 and 12 week |
| Measure | Description | Time Frame |
|---|---|---|
| Insulin (INS) | Changes in INS within groups and between groups | Baseline, 12 week |
| High-sensitivity C-reactive Protein (hs-CRP) | Changes in hs-CRP within groups and between groups |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Agnieszka Kuleta-Koberska, MSc | Contact | +48618467594 | agnieszka.kuleta@up.poznan.pl | |
| Joanna Bajerska, Prof. | Contact | +48618466056 | joanna.bajerska@up.poznan.pl |
| Name | Affiliation | Role |
|---|---|---|
| Agnieszka Kuleta-Koberska, Msc | Poznan University of Life Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Poznan University of Life Science | Recruiting | Poznan | 60-624 | Poland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D024821 | Metabolic Syndrome |
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D035061 | Control Groups |
| ID | Term |
|---|---|
| D015340 | Epidemiologic Research Design |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D012107 | Research Design |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Control group |
| Behavioral |
ESC/EAS Guidelines for the management of dyslipidemias |
|
| Baseline, 12 week |
| Cardiotrophin-1 (CT-1) | Changes in CT-1 within groups and between groups | Baseline, 12 week |
| Lipase (LPS) | Changes in LPS within groups and between groups | Baseline, 12 week |
| Cholinesterase (CHE) | Changes in CHE within groups and between groups respectively | Baseline, 12 week |
| Alanine transaminase (ALT) | Changes in ALT within groups and between groups | Baseline, 12 week |
| Aspartate transaminase (AST) | Changes in AST within groups and between groups | Baseline, 12 week |
| Gamma-glutamyltransferase (GGTP) | Changes in GGTP within groups and between groups | Baseline, 12 week |
| Melatonin (MEL) | Changes in MEL within groups and between groups | Baseline, 12 week |
| Fatty acids (FA) erythrocyte membranes concentration | Changes in FA within groups and between groups | Baseline, 12 week |
| Dietary intake | Changes in dietary intake within groups and between groups | Baseline, 4, 8, 12 week |
| D009750 |
| Nutritional and Metabolic Diseases |
| D008722 | Methods |